Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 3Enrolling by invitation 1Available 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 3Observational 2Expanded_access 1

Sponsor

Cancer Type

Endocrine 3CNS 3

Conditions

Glioma 2Pheochromocytoma 1Parkinsonian Disorders 1Neoplasms 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Endocrine System Diseases 1Congenital Hyperinsulinism 1Carcinoid Tumor 1Brain Neoplasms 1Beckwith-Wiedemann Syndrome 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
fluorodopa F 18 × 90 days × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

NCT00646022 2026-05-12

Natural History of Familial Carcinoid Tumor

National Institutes of Health Clinical Center (CC)

Recruiting
1,600 enrolled
Endocrine

Carcinoid Tumor

NCT06667726 2026-04-28

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Mayo Clinic

Phase 2 Recruiting
47 enrolled
CNS

Brain Neoplasms

NCT01916148 2026-04-27

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Children's Hospital of Philadelphia

Available
Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Nuclear Imaging Institute

Phase 2 Enrolling by invitation
200 enrolled
CNS

Glioma, Neoplasms, Parkinsonian Disorders

NCT02104310 2026-04-06

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Mayo Clinic

Active not recruiting
25 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡